Cargando…

ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis

PURPOSE: The extra spindle pole bodies-like 1 (ESPL1) gene is associated with malignant biological behaviors in several tumors. Nevertheless, the correlation between hepatocellular carcinoma (HCC) and ESPL1 has not been determined. The present study analyzed the molecular function and prognostic val...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Rui, Huang, Juntao, Yang, Chenglei, Li, Yuankuan, Zhan, Guohua, Xiang, Bangde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717693/ https://www.ncbi.nlm.nih.gov/pubmed/36465268 http://dx.doi.org/10.2147/IJGM.S381188

Ejemplares similares

The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma
por: Li, Minjun, et al.
Publicado: (2023)

Comprehensive Analysis of Cuproptosis-Related Genes in Prognosis and Immune Infiltration of Hepatocellular Carcinoma Based on Bulk and Single-Cell RNA Sequencing Data
por: Yang, Chenglei, et al.
Publicado: (2022)

Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy
por: Song, Rui, et al.
Publicado: (2022)

Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study
por: Yang, Chenglei, et al.
Publicado: (2023)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis
por: Wang, Yaobang, et al.
Publicado: (2021)

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
por: Lu, Zhan, et al.
Publicado: (2023)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia
por: Prinzhorn, Wiltrud, et al.
Publicado: (2016)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

MMTV-Espl1 Transgenic Mice Develop Aneuploid, Estrogen Receptor Alpha (ERα)-Positive Mammary Adenocarcinomas
por: Mukherjee, Malini, et al.
Publicado: (2013)

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
por: Zhong, Yuchen, et al.
Publicado: (2023)

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
por: Lu, Zhan, et al.
Publicado: (2023)

EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis
por: Sala, Claudia, et al.
Publicado: (2018)

Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
por: Liu, Qingqing, et al.
Publicado: (2023)

Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma
por: Liu, Xincheng, et al.
Publicado: (2017)

Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data
por: Zeng, Zhili, et al.
Publicado: (2021)

Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
por: Yang, Xihua, et al.
Publicado: (2023)

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
por: Christiani, Eva, et al.
Publicado: (2023)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study
por: Wang, Rongming, et al.
Publicado: (2020)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
por: Chen, Yao, et al.
Publicado: (2021)

Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization
por: Tu, Xinyue, et al.
Publicado: (2023)

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

Prognosis factors of predicting survival in spontaneously ruptured hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2022)

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
por: Wan, Gang, et al.
Publicado: (2017)

Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3
por: Meng, Qiuhua, et al.
Publicado: (2020)

ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
por: Easom, Nicholas J. W., et al.
Publicado: (2020)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
por: Dong, Xiaogang, et al.
Publicado: (2017)

Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line
por: Jiang, Jinghang, et al.
Publicado: (2016)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
por: Zhang, Jie, et al.
Publicado: (2022)

A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
por: Song, Bic-Na, et al.
Publicado: (2018)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_26im7ohrrogkkueajelrmpp5ms